MXPA01010392A - Produccion de vacunas de virus con arn de hebra negativa atenuados a partir de secuencias de nucleotidos clonadas. - Google Patents
Produccion de vacunas de virus con arn de hebra negativa atenuados a partir de secuencias de nucleotidos clonadas.Info
- Publication number
- MXPA01010392A MXPA01010392A MXPA01010392A MXPA01010392A MXPA01010392A MX PA01010392 A MXPA01010392 A MX PA01010392A MX PA01010392 A MXPA01010392 A MX PA01010392A MX PA01010392 A MXPA01010392 A MX PA01010392A MX PA01010392 A MXPA01010392 A MX PA01010392A
- Authority
- MX
- Mexico
- Prior art keywords
- production
- nucleotide sequences
- stranded rna
- rna virus
- virus vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18641—Use of virus, viral particle or viral elements as a vector
- C12N2760/18643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18661—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12900699P | 1999-04-13 | 1999-04-13 | |
PCT/US2000/009695 WO2000061737A2 (en) | 1999-04-13 | 2000-04-12 | Production of attenuated negative stranded rna virus vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01010392A true MXPA01010392A (es) | 2003-09-15 |
Family
ID=22438049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01010392A MXPA01010392A (es) | 1999-04-13 | 2000-04-12 | Produccion de vacunas de virus con arn de hebra negativa atenuados a partir de secuencias de nucleotidos clonadas. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1171623A2 (es) |
JP (1) | JP4646410B2 (es) |
KR (1) | KR100760328B1 (es) |
CN (1) | CN1347458A (es) |
AU (2) | AU781238B2 (es) |
BR (1) | BR0011159A (es) |
CA (1) | CA2369817A1 (es) |
IL (1) | IL145797A0 (es) |
MX (1) | MXPA01010392A (es) |
WO (1) | WO2000061737A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7485440B2 (en) | 1995-09-27 | 2009-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
US6699476B1 (en) | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
JP4413999B2 (ja) | 1996-07-15 | 2010-02-10 | アメリカ合衆国 | クローニングされたヌクレオチド配列からの弱毒化呼吸シンシチウムウィルスワクチンの製造 |
US7192593B2 (en) | 1997-05-23 | 2007-03-20 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
US7951383B2 (en) | 1997-05-23 | 2011-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated parainfluenza virus (PIV) vaccines |
US7632508B2 (en) | 1997-05-23 | 2009-12-15 | The United States Of America | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
US7201907B1 (en) | 1997-05-23 | 2007-04-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines |
US20030082209A1 (en) | 2000-07-05 | 2003-05-01 | Skiadopoulos Mario H. | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
US7662397B2 (en) | 1997-07-15 | 2010-02-16 | The United States Of America As Represented By The Department Of Health And Human Services | Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes |
US20040005542A1 (en) | 2001-06-22 | 2004-01-08 | Krempl Christine D | Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
WO2001004335A2 (en) | 1999-07-09 | 2001-01-18 | The Government Of The United States Of America, As Represented By The Department Of Health And Humanservices | Human-bovine chimeric respiratory syncytial virus vaccines |
DE60114420T2 (de) | 2001-10-04 | 2006-07-13 | Centrum Voor Onderzoek In Diergeneeskunde En Agrochemie | Abgeschwächter Mutantenstamm eines Virus der Newcastle-Krankheit für eine in Ovo Impfung und dessen Benutzung |
EP1572947B1 (en) | 2002-09-18 | 2014-06-25 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
JP2007524372A (ja) | 2003-02-28 | 2007-08-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 組換えヒトメタニューモウイルスおよびその使用 |
WO2004113517A2 (en) | 2003-06-09 | 2004-12-29 | Wyeth | IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
KR20090114431A (ko) * | 2007-02-07 | 2009-11-03 | 디나벡크 가부시키가이샤 | 약독화 마이너스 가닥 rna 바이러스 |
CA2836977A1 (en) * | 2010-06-06 | 2011-12-15 | Benjamin R. Tenoever | Recombinant rna viruses and uses thereof |
CN103525777B (zh) * | 2013-07-01 | 2016-05-18 | 中国农业科学院兰州兽医研究所 | Vii型新城疫病毒l基因突变的减毒疫苗株及其制备方法 |
AU2018298499A1 (en) * | 2017-07-03 | 2020-02-20 | Bharat Biotech International Limited | A synthetic polypeptide epitope based vaccine composition |
KR20200096904A (ko) * | 2017-09-15 | 2020-08-14 | 오하이오 스테이트 이노베이션 파운데이션 | 호흡기 세포융합 바이러스(rsv) 감염의 예방을 위한 백신 및 백신의 제조 및 사용 방법 |
CN111019910B (zh) * | 2019-11-04 | 2022-03-15 | 上海青赛生物科技有限公司 | F基因型腮腺炎病毒减毒株及构建方法和应用 |
CN111849927B (zh) * | 2020-06-28 | 2022-07-08 | 浙江大学 | 高效产生重组不分节段负义rna病毒的方法及重组病毒 |
CN116676275A (zh) * | 2023-03-17 | 2023-09-01 | 北京赛尔富森生物科技有限公司 | A基因型嵌合腮腺炎病毒株和制备方法及用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786199A (en) * | 1989-08-28 | 1998-07-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US5869036A (en) * | 1995-12-08 | 1999-02-09 | St. Louis University | Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
JP4413999B2 (ja) * | 1996-07-15 | 2010-02-10 | アメリカ合衆国 | クローニングされたヌクレオチド配列からの弱毒化呼吸シンシチウムウィルスワクチンの製造 |
-
2000
- 2000-04-12 AU AU42315/00A patent/AU781238B2/en not_active Ceased
- 2000-04-12 MX MXPA01010392A patent/MXPA01010392A/es active IP Right Grant
- 2000-04-12 JP JP2000611661A patent/JP4646410B2/ja not_active Expired - Fee Related
- 2000-04-12 CN CN00806224A patent/CN1347458A/zh active Pending
- 2000-04-12 CA CA002369817A patent/CA2369817A1/en not_active Abandoned
- 2000-04-12 BR BR0011159-7A patent/BR0011159A/pt not_active IP Right Cessation
- 2000-04-12 KR KR1020017013102A patent/KR100760328B1/ko not_active IP Right Cessation
- 2000-04-12 EP EP00922075A patent/EP1171623A2/en not_active Withdrawn
- 2000-04-12 IL IL14579700A patent/IL145797A0/xx not_active IP Right Cessation
- 2000-04-12 WO PCT/US2000/009695 patent/WO2000061737A2/en active Application Filing
-
2005
- 2005-08-12 AU AU2005203596A patent/AU2005203596C1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU4231500A (en) | 2000-11-14 |
AU2005203596B8 (en) | 2009-12-10 |
KR20020008831A (ko) | 2002-01-31 |
JP4646410B2 (ja) | 2011-03-09 |
AU2005203596A1 (en) | 2005-09-08 |
CA2369817A1 (en) | 2000-10-19 |
IL145797A0 (en) | 2002-07-25 |
WO2000061737A3 (en) | 2001-08-23 |
AU781238B2 (en) | 2005-05-12 |
WO2000061737A2 (en) | 2000-10-19 |
CN1347458A (zh) | 2002-05-01 |
EP1171623A2 (en) | 2002-01-16 |
KR100760328B1 (ko) | 2007-10-04 |
AU2005203596B2 (en) | 2008-09-11 |
AU2005203596C1 (en) | 2009-12-10 |
JP2002541798A (ja) | 2002-12-10 |
BR0011159A (pt) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01010392A (es) | Produccion de vacunas de virus con arn de hebra negativa atenuados a partir de secuencias de nucleotidos clonadas. | |
HUP0004115A2 (en) | Novel nucleotide sequences coding for the pck gene | |
AU1824101A (en) | Nucleotide sequences of moraxella catarrhalis genome | |
WO2001047944A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
HUP0003651A3 (en) | Novel nucleotide sequences coding for the pgi gene | |
MXPA01010320A (es) | Produccion de vacunas con virus sincitial respiratorio quimerico atenuado a partir de secuencias nucleotidas clonadas. | |
HUP0104450A3 (en) | Nucleotide sequences for the tal gene | |
ZA200007270B (en) | Novel Nucleotide sequences coding for the zwa2 gene. | |
WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2002046454A3 (de) | Diagnose von mit angiogenese assoziierten krankheiten durch bestimmung der methylierung von mit angiogenese assoziierten genen | |
WO2001040521A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2001048245A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
AU2001293741A1 (en) | Nucleotide sequences coding for the suga gene | |
EP1437408A4 (en) | NOVEL ANTISENSE OLIGONUCLEOTIDE DERIVATIVES AGAINST HEPATITIS C VIRUS | |
ZA200100332B (en) | Novel nucleotide sequences coding for the ptsH gene. | |
AU2001278509A1 (en) | Nucleotide sequences which code for the atr43 gene | |
IL152548A0 (en) | Regulatory nucleic acid sequences of the abc1 gene | |
MXPA02001009A (es) | Virus de la influenza atenuado util como vacuna. | |
AU2001293808A1 (en) | Nucleotide sequences which code for the atr61 gene | |
AU2001291658A1 (en) | Nucleotide sequences which code for the ccpa2 gene | |
AU2002212255A1 (en) | Nucleotide sequences which code for the trub gene | |
AU2002212155A1 (en) | Nucleotide sequences which code for the ppgk gene | |
AU2001293730A1 (en) | Nucleotide sequences which code for the chra gene | |
WO2002083727A3 (de) | Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse | |
AU2002223567A1 (en) | Nucleotide sequences which code for the nadc gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |